Regulus Therapeutics Inc. (NASDAQ: RGLS) announced the appointment of Timothy M. Wright, M.D. as Chief Research and Development (R&D) Officer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE